Catalyst Wire Dossier Catalyst Wire Dossier

ELIXCYTE

· UnicoCell Biomed CO. LTD
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ELIXCYTE, covering 2025-11-21 to 2025-11-21. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of ELIXCYTE Intra-articular Injection in Subject With Knee Osteoarthritis [Phase 3]

See pricing